| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,592 |
5,218 |
$97K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
1,136 |
1,136 |
$25K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,919 |
1,904 |
$20K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
847 |
844 |
$9K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
140 |
140 |
$6K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
588 |
588 |
$5K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
526 |
512 |
$5K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
103 |
103 |
$5K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
519 |
519 |
$4K |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
829 |
829 |
$4K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
804 |
804 |
$4K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
470 |
428 |
$3K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
917 |
881 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
462 |
459 |
$2K |
| 81002 |
|
4,033 |
4,008 |
$2K |
| 90619 |
|
56 |
56 |
$2K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
100 |
100 |
$2K |
| H0001 |
Alcohol and/or drug assessment |
843 |
843 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
4,679 |
4,637 |
$301.49 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
13 |
13 |
$153.44 |
| 96127 |
|
825 |
825 |
$97.60 |
| 90686 |
|
304 |
303 |
$43.04 |
| 99173 |
|
223 |
222 |
$26.67 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
15 |
15 |
$24.12 |
| A7015 |
Aerosol mask, used with dme nebulizer |
13 |
13 |
$3.00 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
13 |
13 |
$2.86 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
13 |
13 |
$2.08 |
| 90651 |
|
97 |
97 |
$0.00 |
| 90647 |
|
28 |
28 |
$0.00 |
| 90674 |
|
164 |
164 |
$0.00 |
| 90680 |
|
92 |
92 |
$0.00 |
| 90697 |
|
77 |
77 |
$0.00 |
| 90723 |
|
27 |
27 |
$0.00 |
| 90715 |
|
15 |
15 |
$0.00 |
| 90671 |
|
121 |
121 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
738 |
738 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
48 |
46 |
$0.00 |
| 90670 |
|
184 |
184 |
$0.00 |
| 90621 |
|
50 |
50 |
$0.00 |
| 90685 |
|
15 |
15 |
$0.00 |
| 90681 |
|
13 |
13 |
$0.00 |
| 90655 |
|
44 |
44 |
$0.00 |
| 90633 |
|
14 |
14 |
$0.00 |